P1115: A MULTICENTER PHASE 1/2 TRIAL OF EO2463, A MICROBIAL-DERIVED PEPTIDE THERAPEUTIC VACCINE, AS MONOTHERAPY AND IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB, FOR TREATMENT OF...

por Zinzani, P. L., Ansell, S. M., Bosch, F., Friedberg, J. W., Marolleau, J. P., Arcaini, L., Garcia-Sanz, R., Gopal, A. K., Grande, C., Merryman, R., Pinto, A., Smith, S. D., Villasboas, J. C., Wallace, D., Fagerberg, J., Magalhaes, J. G., Armand, P.
Publicado 2022